Concepedia

P. Hulo

PH

Statistics

Publications

1

Citations

23

H-Index

1

Active since

2023

Affiliations

Institut de Cancérologie de l'Ouest(Current)

P. Hulo is an author at Institut de Cancérologie de l'Ouest specializing in oncology, pembrolizumab therapy, and cancer survival analysis.

Publications per year

2023–2023

1

Publications

1

Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%

Elvire Pons‐Tostivint, P. Hulo, V. Guardiolle et al. · Cancer Immunology Immunotherapy · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +7

1–1 of 1